Repligen | أصول متداولة



Current Assets تغيير تاريخ
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.4B 90.41M 2025-03
Bio Techne USD 634.64M 13.93M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Bruker USD 2.06B 133.1M 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Danaher USD 9.52B 28M 2025-03
Dentsply International USD 1.75B 175M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
General Electric USD 37.58B 60M 2025-03
Henry Schein USD 3.98B 164M 2024-12
Illumina USD 2.75B 373M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Mettler Toledo International USD 1.19B 4.33M 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.32B 31.67M 2025-03
Standard Biotools USD 375.88M 77.73M 2024-12
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Waters USD 1.67B 21.39M 2024-12
West Pharmaceutical Services USD 1.46B 80.6M 2025-03



Repligen أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.